Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Ischemic Heart Disease

Free Subscription 29.10.2018 2 Am Heart J 3 Am J Cardiol 2 Angiology 1 Ann Intern Med 3 Ann Thorac Surg 4 Arterioscler Thromb Vasc Biol 1 Atherosclerosis 2 BMJ 1 Catheter Cardiovasc Interv 1 Circ Arrhythm Electrophysiol 3 Circ Cardiovasc Imaging 21 Circ Cardiovasc Interv 13 Circ Cardiovasc Qual Outcomes 7 Circ Genom Precis Med 17 Circ Res 39 Circulation 2 Clin Cardiol 2 Eur Heart J 5 Heart 7 Hypertension 31 Int J Cardiol 13 J Am Coll Cardiol 1 J Cardiovasc Pharmacol 1 J Electrocardiol 1 J Mol Cell Cardiol 1 J Thorac Cardiovasc Surg 2 JAMA 1 Lancet 1 Lancet Child Adolesc Health 3 N Engl J Med 2 PLoS One

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Am Heart J

1. PRADHAN AD, Paynter NP, Everett BM, Glynn RJ, et al
   Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study.
   Am Heart J. 2018;206:80-93.
   PubMed     Text format     Abstract available
   
   
2. HARRISON RW, Radhakrishnan V, Allen JC Jr, Lam PS, et al
   The East-West late lumen loss study: Comparison of angiographic late lumen loss between Eastern and Western drug-eluting stent study cohorts.
   Am Heart J. 2018;206:61-71.
   PubMed     Text format     Abstract available
   
   

   
   Am J Cardiol

3. MURRAY J, Balmuri A, Saurav A, Smer A, et al
   Impact of Chronic Kidney Disease on Utilization of Coronary Angiography and Percutaneous Coronary Intervention, and Their Outcomes in Patients With Non-ST Elevation Myocardial Infarction.
   Am J Cardiol. 2018 Sep 8. pii: S0002-9149(18)31723.
   PubMed     Text format     Abstract available
   
   
4. KORJIAN S, Braunwald E, Daaboul Y, Mi M, et al
   Usefulness of Rivaroxaban for Secondary Prevention of Acute Coronary Syndrome in Patients With History of Congestive Heart Failure (from the ATLAS-ACS-2 TIMI-51 Trial).
   Am J Cardiol. 2018 Sep 7. pii: S0002-9149(18)31733.
   PubMed     Text format     Abstract available
   
   
5. ELBADAWI A, Elgendy IY, Ha LD, Mahmoud K, et al
   National Trends and Outcomes of Percutaneous Coronary Intervention in Patients >/=70 Years of Age With Acute Coronary Syndrome (from the National Inpatient Sample Database).
   Am J Cardiol. 2018 Sep 27. pii: S0002-9149(18)31851.
   PubMed     Text format     Abstract available
   
   

   
   Angiology

6. KARAKURT M, Acar B, Ozeke O, Ozbay MB, et al
   From the Obesity Tsunami to the Diabetes Avalanche: Primordial Prevention of the Diabesity-Related Cardiovascular Epidemic by Diabeto-Cardiologists.
   Angiology. 2018 Oct 24:3319718808921. doi: 10.1177/0003319718808921.
   PubMed     Text format    
   
   
7. ICEN YK, Koc AS, Sumbul HE
   Reply to the Letter to the Editor Entitled ''Coronary Artery Disease Severity Is Associated With Abdominal Aortic Intima-Media Thickness in Patients With Non-ST-Segment Elevation Myocardial Infarction''.
   Angiology. 2018 Oct 24:3319718808391. doi: 10.1177/0003319718808391.
   PubMed     Text format    
   
   

   
   Ann Intern Med

8. GROSSO G, Sippl N, Kjellstrom B, Amara K, et al
   Antiphospholipid Antibodies in Patients With Myocardial Infarction.
   Ann Intern Med. 2018 Oct 23. pii: 2709123. doi: 10.7326/M18-2130.
   PubMed     Text format    
   
   

   
   Ann Thorac Surg

9. KAVARANA MN
   Anomalous Aortic Origin of the Coronary Arteries: A Novel Unroofing Technique in an Adult Cohort (Commentary).
   Ann Thorac Surg. 2018 Oct 23. pii: S0003-4975(18)31514.
   PubMed     Text format    
   
   
10. HWANG HY, Koo BK, Yeom SY, Kim TK, et al
    Endothelial Shear Stress of the Saphenous Vein Composite Graft Based on the Internal Thoracic Artery.
    Ann Thorac Surg. 2018;105:564-571.
    PubMed     Text format     Abstract available
    
    
11. FRASER CD 3RD, Zhou X, Liu RH, Lui C, et al
    Coronary Button Pseudoaneurysms After Aortic Root Replacement in a Child With Loeys-Deitz Syndrome.
    Ann Thorac Surg. 2018;105:e63-e65.
    PubMed     Text format     Abstract available
    
    

    
    Arterioscler Thromb Vasc Biol

12. GHAFFARI S, Naderi Nabi F, Sugiyama MG, Lee WL, et al
    Estrogen Inhibits LDL (Low-Density Lipoprotein) Transcytosis by Human Coronary Artery Endothelial Cells via GPER (G-Protein-Coupled Estrogen Receptor) and SR-BI (Scavenger Receptor Class B Type 1).
    Arterioscler Thromb Vasc Biol. 2018;38:2283-2294.
    PubMed     Text format     Abstract available
    
    
13. HA EE, Bauer RC
    Emerging Roles for Adipose Tissue in Cardiovascular Disease.
    Arterioscler Thromb Vasc Biol. 2018;38:e137-e144.
    PubMed     Text format    
    
    
14. WONG YK, Cheung CYY, Tang CS, Au KW, et al
    Age-Biomarkers-Clinical Risk Factors for Prediction of Cardiovascular Events in Patients With Coronary Artery Disease.
    Arterioscler Thromb Vasc Biol. 2018;38:2519-2527.
    PubMed     Text format     Abstract available
    
    
15. GUPTA RM
    Hippo Pathway Looms Large for the Function of the JCAD (Junctional Protein Associated With Coronary Artery Disease) on Endothelial Cells.
    Arterioscler Thromb Vasc Biol. 2018;38:2546-2547.
    PubMed     Text format    
    
    

    
    Atherosclerosis

16. KANURI SH, Ipe J, Kassab K, Gao H, et al
    Next generation MicroRNA sequencing to identify coronary artery disease patients at risk of recurrent myocardial infarction.
    Atherosclerosis. 2018;278:232-239.
    PubMed     Text format     Abstract available
    
    

    
    BMJ

17. LAI HT, de Oliveira Otto MC, Lemaitre RN, McKnight B, et al
    Serial circulating omega 3 polyunsaturated fatty acids and healthy ageing among older adults in the Cardiovascular Health Study: prospective cohort study.
    BMJ. 2018;363:k4067.
    PubMed     Text format     Abstract available
    
    
18. 
    Serial circulating omega 3 polyunsaturated fatty acids and healthy ageing among older adults in the Cardiovascular Health Study: prospective cohort study.
    BMJ. 2018;363:k4445.
    PubMed     Text format    
    
    

    
    Catheter Cardiovasc Interv

19. GE Z, Baber U, Claessen BE, Farhan S, et al
    The prevalence, predictors and outcomes of guideline-directed medical therapy in patients with acute myocardial infarction undergoing PCI, an analysis from the PROMETHEUS registry.
    Catheter Cardiovasc Interv. 2018 Oct 23. doi: 10.1002/ccd.27860.
    PubMed     Text format     Abstract available
    
    

    
    Circ Arrhythm Electrophysiol

20. DUPREZ DA, Heckbert SR, Alonso A, Gross MD, et al
    Collagen Biomarkers and Incidence of New Onset of Atrial Fibrillation in Subjects With No Overt Cardiovascular Disease at Baseline.
    Circ Arrhythm Electrophysiol. 2018;11:e006557.
    PubMed     Text format     Abstract available
    
    

    
    Circ Cardiovasc Imaging

21. BITTNER DO, Mayrhofer T, Puchner SB, Lu MT, et al
    Coronary Computed Tomography Angiography-Specific Definitions of High-Risk Plaque Features Improve Detection of Acute Coronary Syndrome.
    Circ Cardiovasc Imaging. 2018;11:e007657.
    PubMed     Text format     Abstract available
    
    
22. MODIN D, Biering-Sorensen SR, Mogelvang R, Jensen JS, et al
    Prognostic Importance of Left Ventricular Mechanical Dyssynchrony in Predicting Cardiovascular Death in the General Population.
    Circ Cardiovasc Imaging. 2018;11:e007528.
    PubMed     Text format     Abstract available
    
    
23. KUTTY S, Bisselou Moukagna KS, Craft M, Shostrom V, et al
    Clinical Outcome of Patients With Inducible Capillary Blood Flow Abnormalities During Demand Stress in the Presence or Absence of Angiographic Coronary Disease.
    Circ Cardiovasc Imaging. 2018;11:e007483.
    PubMed     Text format     Abstract available
    
    

    
    Circ Cardiovasc Interv

24. ALKHALIL M, Choudhury RP
    Reperfusion Treatment in Late Presentation Acute Myocardial Infarction.
    Circ Cardiovasc Interv. 2018;11:e007287.
    PubMed     Text format    
    
    
25. BRILAKIS ES, Burke MN
    Chronic Total Occlusion Percutaneous Coronary Intervention.
    Circ Cardiovasc Interv. 2018;11:e007362.
    PubMed     Text format    
    
    
26. KHATANA SAM, Fiorilli PN, Nathan AS, Kolansky DM, et al
    Association Between 30-Day Mortality After Percutaneous Coronary Intervention and Education and Certification Variables for New York State Interventional Cardiologists.
    Circ Cardiovasc Interv. 2018;11:e006094.
    PubMed     Text format     Abstract available
    
    
27. YAMAJI K, Zanchin T, Zanchin C, Stortecky S, et al
    Unselected Use of Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent for Coronary Revascularization.
    Circ Cardiovasc Interv. 2018;11:e006741.
    PubMed     Text format     Abstract available
    
    
28. NEPPER-CHRISTENSEN L, Lonborg J, Hofsten DE, Ahtarovski KA, et al
    Benefit From Reperfusion With Primary Percutaneous Coronary Intervention Beyond 12 Hours of Symptom Duration in Patients With ST-Segment-Elevation Myocardial Infarction.
    Circ Cardiovasc Interv. 2018;11:e006842.
    PubMed     Text format     Abstract available
    
    
29. BRENER SJ, Kirtane AJ, Rinaldi MJ, Stuckey TD, et al
    Prediction of Ischemic and Bleeding Events Using the Dual Antiplatelet Therapy Score in an Unrestricted Percutaneous Coronary Intervention Population.
    Circ Cardiovasc Interv. 2018;11:e006853.
    PubMed     Text format     Abstract available
    
    
30. VARGHESE MJ, Bhatheja S, Baber U, Kezbor S, et al
    Intravascular Brachytherapy for the Management of Repeated Multimetal-Layered Drug-Eluting Coronary Stent Restenosis.
    Circ Cardiovasc Interv. 2018;11:e006832.
    PubMed     Text format     Abstract available
    
    
31. ROGUIN A, Kandzari DE, Marcusohn E, Koolen JJ, et al
    Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients.
    Circ Cardiovasc Interv. 2018;11:e007331.
    PubMed     Text format     Abstract available
    
    
32. ABDEL-WAHAB M, Toelg R, Byrne RA, Geist V, et al
    High-Speed Rotational Atherectomy Versus Modified Balloons Prior to Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions.
    Circ Cardiovasc Interv. 2018;11:e007415.
    PubMed     Text format     Abstract available
    
    
33. KANDZARI DE, Gershlick AH, Serruys PW, Leon MB, et al
    Outcomes Among Patients Undergoing Distal Left Main Percutaneous Coronary Intervention.
    Circ Cardiovasc Interv. 2018;11:e007007.
    PubMed     Text format     Abstract available
    
    
34. 
    Correction to: High-Speed Rotational Atherectomy Versus Modified Balloons Before Drug-Eluting Stent Implantation in Severely Calcified Coronary Lesions: The Randomized PREPARE-CALC Trial.
    Circ Cardiovasc Interv. 2018;11:e000040.
    PubMed     Text format    
    
    
35. BAGUR R, Jolly SS
    Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.
    Circ Cardiovasc Interv. 2018;11:e007368.
    PubMed     Text format    
    
    
36. BERRY NC, Kereiakes DJ, Yeh RW, Steg PG, et al
    Benefit and Risk of Prolonged DAPT After Coronary Stenting in Women.
    Circ Cardiovasc Interv. 2018;11:e005308.
    PubMed     Text format     Abstract available
    
    
37. DANCHIN N, Puymirat E, Cayla G, Cottin Y, et al
    One-Year Survival After ST-Segment-Elevation Myocardial Infarction in Relation With Prehospital Administration of Dual Antiplatelet Therapy.
    Circ Cardiovasc Interv. 2018;11:e007241.
    PubMed     Text format     Abstract available
    
    
38. LEMKES JS, Janssens GN, van Royen N
    Letter by Lemkes et al Regarding Article, "Emergency Coronary Angiography After Out-of-Hospital Cardiac Arrest: Is It Essential or Futile?"
    Circ Cardiovasc Interv. 2018;11:e007118.
    PubMed     Text format    
    
    
39. MCGRATH-CADELL L, Holloway CJ
    Early Aftermath of Spontaneous Coronary Artery Dissection.
    Circ Cardiovasc Interv. 2018;11:e007237.
    PubMed     Text format    
    
    
40. 
    Correction to: Incidence, Predictors, and Outcomes of Acquired Thrombocytopenia After Percutaneous Coronary Intervention: A Pooled, Patient-Level Analysis of the CHAMPION Trials (Cangrelor Versus Standard Therapy to Achieve Optimal Management of Plate
    Circ Cardiovasc Interv. 2018;11:e000036.
    PubMed     Text format    
    
    
41. MASON PJ, Shah B, Tamis-Holland JE, Bittl JA, et al
    An Update on Radial Artery Access and Best Practices for Transradial Coronary Angiography and Intervention in Acute Coronary Syndrome: A Scientific Statement From the American Heart Association.
    Circ Cardiovasc Interv. 2018;11:e000035.
    PubMed     Text format     Abstract available
    
    
42. BYRNE RA, Colleran R, Kastrati A
    Strengths and Limitations of Real World Data in Patients Treated With Coronary Stents.
    Circ Cardiovasc Interv. 2018;11:e007239.
    PubMed     Text format    
    
    
43. 
    Correction to: Circulation: Cardiovascular Interventions: The First 10 Years.
    Circ Cardiovasc Interv. 2018;11:e000037.
    PubMed     Text format    
    
    
44. WATERBURY TM, Tweet MS, Hayes SN, Eleid MF, et al
    Early Natural History of Spontaneous Coronary Artery Dissection.
    Circ Cardiovasc Interv. 2018;11:e006772.
    PubMed     Text format     Abstract available
    
    

    
    Circ Cardiovasc Qual Outcomes

45. BYKOV K, Gagne JJ, Wang B, Choudhry NK, et al
    Impact of a Metoprolol Extended Release Shortage on Post-Myocardial Infarction beta-Blocker Utilization, Adherence, and Rehospitalization.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004096.
    PubMed     Text format     Abstract available
    
    
46. WASFY JH, Kennedy KF, Masoudi FA, Ferris TG, et al
    Predicting Length of Stay and the Need for Postacute Care After Acute Myocardial Infarction to Improve Healthcare Efficiency.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004635.
    PubMed     Text format     Abstract available
    
    
47. NALLAMOTHU BK
    Circulation: Cardiovascular Quality and Outcomes Introduces Its New Commentators.
    Circ Cardiovasc Qual Outcomes. 2018;11:e005129.
    PubMed     Text format    
    
    
48. LANGE DC, Conte S, Pappas-Block E, Hildebrandt D, et al
    Cancellation of the Cardiac Catheterization Lab After Activation for ST-Segment-Elevation Myocardial Infarction.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004464.
    PubMed     Text format     Abstract available
    
    
49. VALLE JA, Glorioso TJ, Maddox TM, Armstrong EJ, et al
    Impact of Patient Distance From Percutaneous Coronary Intervention Centers on Longitudinal Outcomes.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004623.
    PubMed     Text format     Abstract available
    
    
50. 
    Correction to: Effect of a Computer-Guided, Quality Improvement Program for Cardiovascular Disease Risk Management in Primary Health Care: The Treatment of Cardiovascular Risk Using Electronic Decision Support Cluster-Randomized Trial.
    Circ Cardiovasc Qual Outcomes. 2018;11:e000049.
    PubMed     Text format    
    
    
51. JACKSON CA, Sudlow CLM, Mishra GD
    Psychological Distress and Risk of Myocardial Infarction and Stroke in the 45 and Up Study.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004500.
    PubMed     Text format     Abstract available
    
    
52. 
    Correction to: Medicare Accountable Care Organizations Are Not Associated With Reductions in the Use of Low-Value Coronary Revascularization.
    Circ Cardiovasc Qual Outcomes. 2018;11:e000047.
    PubMed     Text format    
    
    
53. SINHA SS, Moloci NM, Ryan AM, Markovitz AA, et al
    The Effect of Medicare Accountable Care Organizations on Early and Late Payments for Cardiovascular Disease Episodes.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004495.
    PubMed     Text format     Abstract available
    
    
54. MANEMANN SM, Chamberlain AM, Boyd CM, Miller DM, et al
    Fall Risk and Outcomes Among Patients Hospitalized With Cardiovascular Disease in the Community.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004199.
    PubMed     Text format     Abstract available
    
    
55. KINI V, Peterson PN, Spertus JA, Kennedy KF, et al
    Clinical Model to Predict 90-Day Risk of Readmission After Acute Myocardial Infarction.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004788.
    PubMed     Text format     Abstract available
    
    
56. COLUMBO JA, Kang R, Trooboff SW, Jahn KS, et al
    Validating Publicly Available Crosswalks for Translating ICD-9 to ICD-10 Diagnosis Codes for Cardiovascular Outcomes Research.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004782.
    PubMed     Text format     Abstract available
    
    
57. LOH JP, Tan LL, Zheng H, Lau YH, et al
    First Medical Contact-to-Device Time and Heart Failure Outcomes Among Patients Undergoing Primary Percutaneous Coronary Intervention.
    Circ Cardiovasc Qual Outcomes. 2018;11:e004699.
    PubMed     Text format     Abstract available
    
    

    
    Circ Genom Precis Med

58. TRAGANTE V, Hemerich D, Alshabeeb M, Braenne I, et al
    Druggability of Coronary Artery Disease Risk Loci.
    Circ Genom Precis Med. 2018;11:e001977.
    PubMed     Text format     Abstract available
    
    
59. HAJEK C, Guo X, Yao J, Hai Y, et al
    Coronary Heart Disease Genetic Risk Score Predicts Cardiovascular Disease Risk in Men, Not Women.
    Circ Genom Precis Med. 2018;11:e002324.
    PubMed     Text format    
    
    
60. SILBERBACH M, Roos-Hesselink JW, Andersen NH, Braverman AC, et al
    Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association.
    Circ Genom Precis Med. 2018;11:e000048.
    PubMed     Text format     Abstract available
    
    
61. BAZZELL BG, Rainey WE, Auchus RJ, Zocco D, et al
    Human Urinary mRNA as a Biomarker of Cardiovascular Disease.
    Circ Genom Precis Med. 2018;11:e002213.
    PubMed     Text format     Abstract available
    
    
62. VAN DER LAAN SW, Siemelink MA, Haitjema S, Foroughi Asl H, et al
    Genetic Susceptibility Loci for Cardiovascular Disease and Their Impact on Atherosclerotic Plaques.
    Circ Genom Precis Med. 2018;11:e002115.
    PubMed     Text format     Abstract available
    
    
63. 
    Correction to: APOL1 Sends Its REGARDS to Cardiovascular Disease.
    Circ Genom Precis Med. 2018;11:e000049.
    PubMed     Text format    
    
    
64. 
    Correction to: Birthweight, Type 2 Diabetes Mellitus, and Cardiovascular Disease: Addressing the Barker Hypothesis With Mendelian Randomization.
    Circ Genom Precis Med. 2018;11:e000051.
    PubMed     Text format    
    
    

    
    Circ Res

65. ZHANG W, Song M, Qu J, Liu GH, et al
    Epigenetic Modifications in Cardiovascular Aging and Diseases.
    Circ Res. 2018;123:773-786.
    PubMed     Text format     Abstract available
    
    
66. ABDELLATIF M, Sedej S, Carmona-Gutierrez D, Madeo F, et al
    Autophagy in Cardiovascular Aging.
    Circ Res. 2018;123:803-824.
    PubMed     Text format     Abstract available
    
    
67. CHIA CW, Egan JM, Ferrucci L
    Age-Related Changes in Glucose Metabolism, Hyperglycemia, and Cardiovascular Risk.
    Circ Res. 2018;123:886-904.
    PubMed     Text format     Abstract available
    
    
68. 
    Correction to: Pleiotropic Effects of Statins on the Cardiovascular System.
    Circ Res. 2018;123:e20.
    PubMed     Text format    
    
    
69. FRATI G, Vecchione C, Sciarretta S
    Novel Beneficial Cardiovascular Effects of Natural Activators of Autophagy.
    Circ Res. 2018;123:947-949.
    PubMed     Text format    
    
    
70. TECHIRYAN G, Weil BR, Palka BA, Canty JM Jr, et al
    Effect of Intracoronary Metformin on Myocardial Infarct Size in Swine.
    Circ Res. 2018;123:986-995.
    PubMed     Text format     Abstract available
    
    
71. YU C, Xue H, Wang L, Chen Q, et al
    Serum Bioavailable and Free 25-Hydroxyvitamin D Levels, but Not Its Total Level, Are Associated With the Risk of Mortality in Patients With Coronary Artery Disease.
    Circ Res. 2018;123:996-1007.
    PubMed     Text format     Abstract available
    
    
72. KANE AE, Sinclair DA
    Sirtuins and NAD(+) in the Development and Treatment of Metabolic and Cardiovascular Diseases.
    Circ Res. 2018;123:868-885.
    PubMed     Text format     Abstract available
    
    
73. MARIAN AJ, Bhatnagar A, Bolli R, Izpisua Belmonte JC, et al
    Introduction to Cardiovascular Aging Compendium.
    Circ Res. 2018;123:737-739.
    PubMed     Text format    
    
    
74. TAYLOR DA, Willerson JT
    Racial Disparities in CD34+ Cells and Their Influence on Cardiovascular Repair.
    Circ Res. 2018;123:401-403.
    PubMed     Text format    
    
    
75. SCHEEN AJ
    Do Positive Cardiovascular Outcomes Trials With New Glucose-Lowering Agents Overestimate Both Efficacy and Safety?
    Circ Res. 2018;123:e3-e4.
    PubMed     Text format    
    
    
76. TAMPAKI EC, Tampakis A, Gurke L, Pantos C, et al
    Letter by Tampaki et al Regarding Article, "Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors".
    Circ Res. 2018;123:e1-e2.
    PubMed     Text format    
    
    
77. COOPER HA, Scalia R, Rizzo V, Eguchi S, et al
    Angiotensin II- and Alzheimer-Type Cardiovascular Aging.
    Circ Res. 2018;123:651-653.
    PubMed     Text format    
    
    
78. MONTAIGNE D, Staels B
    Time to Check the Clock in Cardiovascular Research and Medicine.
    Circ Res. 2018;123:648-650.
    PubMed     Text format    
    
    
79. MCNAMARA JW, Grimes KM, Sadayappan S
    Basic Cardiovascular Sciences Scientific Sessions 2018.
    Circ Res. 2018;123:1024-1029.
    PubMed     Text format    
    
    
80. MALIK M, Suboc TM, Tyagi S, Salzman N, et al
    Lactobacillus plantarum 299v Supplementation Improves Vascular Endothelial Function and Reduces Inflammatory Biomarkers in Men With Stable Coronary Artery Disease.
    Circ Res. 2018;123:1091-1102.
    PubMed     Text format     Abstract available
    
    
81. LI Z, Polhemus DJ, Lefer DJ
    Evolution of Hydrogen Sulfide Therapeutics to Treat Cardiovascular Disease.
    Circ Res. 2018;123:590-600.
    PubMed     Text format     Abstract available
    
    

    
    Circulation

82. CHAPMAN AR, Hesse K, Andrews J, Ken Lee K, et al
    High-Sensitivity Cardiac Troponin I and Clinical Risk Scores in Patients With Suspected Acute Coronary Syndrome.
    Circulation. 2018;138:1654-1665.
    PubMed     Text format     Abstract available
    
    
83. NICCOLI G, Montone RA, Sabato V, Crea F, et al
    Role of Allergic Inflammatory Cells in Coronary Artery Disease.
    Circulation. 2018;138:1736-1748.
    PubMed     Text format     Abstract available
    
    
84. BONELLO L, Angiolillo DJ, Aradi D, Sibbing D, et al
    P2Y12-ADP Receptor Blockade in Chronic Kidney Disease Patients With Acute Coronary Syndromes.
    Circulation. 2018;138:1582-1596.
    PubMed     Text format     Abstract available
    
    
85. CLAGGETT B, Lachin JM, Hantel S, Fitchett D, et al
    Long-Term Benefit of Empagliflozin on Life Expectancy in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease.
    Circulation. 2018;138:1599-1601.
    PubMed     Text format    
    
    
86. VERMA S, Leiter LA, Mazer CD, Bain SC, et al
    Liraglutide Reduces Cardiovascular Events and Mortality in Type 2 Diabetes Mellitus Independently of Baseline Low-Density Lipoprotein Cholesterol Levels and Statin Use.
    Circulation. 2018;138:1605-1607.
    PubMed     Text format    
    
    
87. JAMES M, Manns B
    Neprilysin Inhibition and Effects on Kidney Function and Surrogates of Cardiovascular Risk in Chronic Kidney Disease.
    Circulation. 2018;138:1515-1518.
    PubMed     Text format    
    
    
88. YASUDA S, Miyamoto Y, Ogawa H
    Current Status of Cardiovascular Medicine in the Aging Society of Japan.
    Circulation. 2018;138:965-967.
    PubMed     Text format    
    
    
89. LOWENSTEIN CJ, Weisfeldt ML, Mitchell JH
    Sarnoff Cardiovascular Research Foundation.
    Circulation. 2018;138:554-556.
    PubMed     Text format    
    
    
90. BODEN WE, Bhatt DL
    Will COMPASS Point to a New Direction in Thrombotic Risk Reduction in Patients With Stable Cardiovascular Disease?
    Circulation. 2018;138:858-860.
    PubMed     Text format    
    
    
91. RODEN DM
    Growing Pains in Cardiovascular Genetics.
    Circulation. 2018;138:1206-1209.
    PubMed     Text format    
    
    
92. KAHN HS
    Letter by Kahn Regarding Article, "Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management".
    Circulation. 2018;138:1494-1495.
    PubMed     Text format    
    
    
93. NEELAND IJ, Poirier P, Despres JP
    Response by Neeland et al to Letter Regarding Article, "Cardiovascular and Metabolic Heterogeneity of Obesity: Clinical Challenges and Implications for Management".
    Circulation. 2018;138:1496-1497.
    PubMed     Text format    
    
    
94. WENGER NK, Lorell BH, Bairey Merz CN
    Recent Legislation, Public Policy Changes, and Women's Cardiovascular Health.
    Circulation. 2018;138:1082-1084.
    PubMed     Text format    
    
    
95. HSUE PY, Waters DD
    Time to Recognize HIV Infection as a Major Cardiovascular Risk Factor.
    Circulation. 2018;138:1113-1115.
    PubMed     Text format    
    
    
96. WHITE WB
    Gout, Xanthine Oxidase Inhibition, and Cardiovascular Outcomes.
    Circulation. 2018;138:1127-1129.
    PubMed     Text format    
    
    
97. KUEHN BM
    Boosting Women's Participation in Cardiovascular Trials.
    Circulation. 2018;138:1366-1367.
    PubMed     Text format    
    
    
98. GIMPEL D, Ray M
    Time to Get a @Handle on Twitter and Cardiovascular Medicine.
    Circulation. 2018;138:1285-1286.
    PubMed     Text format    
    
    
99. ROLLINI F, Franchi F
    Standard- and Low-Dose Ticagrelor After Percutaneous Coronary Intervention.
    Circulation. 2018;138:1301-1303.
    PubMed     Text format    
    
    
100. DINU M, Pagliai G, Sofi F
     Response by Dinu et al to Letters Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
     Circulation. 2018;138:655.
     PubMed     Text format    
     
     
101. KOH KK
     Letter by Koh Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
     Circulation. 2018;138:651-652.
     PubMed     Text format    
     
     
102. HANDY CE, Quispe R, Pinto X, Blaha MJ, et al
     Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment.
     Circulation. 2018;138:727-734.
     PubMed     Text format     Abstract available
     
     
103. KYRLE PA, Eichinger S
     D-Dimer for Long-Term Risk Prediction in Patients After Acute Coronary Syndrome.
     Circulation. 2018;138:724-726.
     PubMed     Text format    
     
     
104. KASKI JC, Crea F, Gersh BJ, Camici PG, et al
     Reappraisal of Ischemic Heart Disease.
     Circulation. 2018;138:1463-1480.
     PubMed     Text format     Abstract available
     
     
105. LINDOW T, Warren S, Pahlm O
     Two Patients With Inferior ST-Segment-Elevation Myocardial Infarction.
     Circulation. 2018;138:1481-1484.
     PubMed     Text format    
     
     
106. MADIAS JE
     Letter by Madias Regarding Article, "Long-Term Outcomes in Patients With Type 2 Myocardial Infarction and Myocardial Injury".
     Circulation. 2018;138:1176-1177.
     PubMed     Text format    
     
     
107. SHARKEY SW, Maron BJ, Kloner RA
     The Case for Takotsubo Cardiomyopathy (Syndrome) as a Variant of Acute Myocardial Infarction.
     Circulation. 2018;138:855-857.
     PubMed     Text format    
     
     
108. ZAUNER CA, Holshouser JW, Littmann L
     Response to Letter Regarding Article, "Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease".
     Circulation. 2018;138:853-854.
     PubMed     Text format    
     
     
109. YI-TONG W
     Letter by Wang Yi-tong Regarding Article, "Ventricular Tachycardia and Electrocardiographic ST-Segment-Elevation Myocardial Infarction Without Coronary Artery Disease".
     Circulation. 2018;138:852.
     PubMed     Text format    
     
     
110. TAMPAKIS A, Tampaki EC, Gurke L
     Letter by Tampakis et al Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
     Circulation. 2018;138:848-849.
     PubMed     Text format    
     
     
111. WANNER C, von Eynatten M, Zinman B
     Response by Wanner et al to Letters Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
     Circulation. 2018;138:850-851.
     PubMed     Text format    
     
     
112. KOH KK
     Letter by Koh Regarding Article, "Empagliflozin and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus, Established Cardiovascular Disease, and Chronic Kidney Disease".
     Circulation. 2018;138:846-847.
     PubMed     Text format    
     
     
113. INZUCCHI SE, Kosiborod M, Fitchett D, Wanner C, et al
     Improvement in Cardiovascular Outcomes With Empagliflozin Is Independent of Glycemic Control.
     Circulation. 2018;138:1904-1907.
     PubMed     Text format    
     
     
114. DONZELLI A, Schivalocchi A, Giudicatti G
     Letter by Donzelli et al Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Effica
     Circulation. 2018;138:1912-1913.
     PubMed     Text format    
     
     
115. KOH KK
     Letter by Koh Regarding Article, "Benefit of Adding Ezetimibe to Statin Therapy on Cardiovascular Outcomes and Safety in Patients With Versus Without Diabetes Mellitus: Results From IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy Internat
     Circulation. 2018;138:1914-1915.
     PubMed     Text format    
     
     
116. KHERA A, Budoff MJ, O'Donnell CJ, Ayers CA, et al
     Astronaut Cardiovascular Health and Risk Modification (Astro-CHARM) Coronary Calcium Atherosclerotic Cardiovascular Disease Risk Calculator.
     Circulation. 2018;138:1819-1827.
     PubMed     Text format     Abstract available
     
     
117. NISHI T, Piroth Z, De Bruyne B, Jagic N, et al
     Fractional Flow Reserve and Quality-of-Life Improvement After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease.
     Circulation. 2018;138:1797-1804.
     PubMed     Text format     Abstract available
     
     
118. MATTHEWS DR, Perkovic V, Mahaffey KW
     Letter by Matthews et al Regarding Article, "Class Effect for Sodium Glucose-Cotransporter-2 Inhibitors in Cardiovascular Outcomes: Implications for the Cardiovascular Disease Specialist".
     Circulation. 2018;138:660-661.
     PubMed     Text format    
     
     
119. HNID K
     Letter by Hnid Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
     Circulation. 2018;138:653-654.
     PubMed     Text format    
     
     
120. YE Z, Su Q, Li L
     Letter by Ye et al Regarding Article, "Low-Calorie Vegetarian Versus Mediterranean Diets for Reducing Body Weight and Improving Cardiovascular Risk Profile: CARDIVEG Study (Cardiovascular Prevention With Vegetarian Diet)".
     Circulation. 2018;138:649-650.
     PubMed     Text format    
     
     

     
     Clin Cardiol

121. GUARICCI AI, Lorenzoni V, Guglielmo M, Mushtaq S, et al
     Prognostic relevance of subclinical coronary and carotid atherosclerosis in a diabetic and nondiabetic asymptomatic population.
     Clin Cardiol. 2018;41:769-777.
     PubMed     Text format     Abstract available
     
     
122. GUNJA A, Stanislawski MA, Baron AE, Maddox TM, et al
     The implications of cocaine use and associated behaviors on adverse cardiovascular outcomes among veterans: Insights from the VA Clinical Assessment, Reporting, and Tracking (CART) Program.
     Clin Cardiol. 2018;41:809-816.
     PubMed     Text format     Abstract available
     
     

     
     Eur Heart J

123. HERITIER H, Vienneau D, Foraster M, Eze IC, et al
     A systematic analysis of mutual effects of transportation noise and air pollution exposure on myocardial infarction mortality: a nationwide cohort study in Switzerland.
     Eur Heart J. 2018 Oct 24. pii: 5144026. doi: 10.1093.
     PubMed     Text format     Abstract available
     
     
124. WALLENTIN L
     Different perspectives on outcomes in patients with non-ST-elevation myocardial infarction when observed in clinical trials and in real life.
     Eur Heart J. 2018 Oct 17. pii: 5137113. doi: 10.1093.
     PubMed     Text format    
     
     

     
     Heart

125. TESTORI C, Beitzke D, Mangold A, Sterz F, et al
     Out-of-hospital initiation of hypothermia in ST-segment elevation myocardial infarction: a randomised trial.
     Heart. 2018 Oct 25. pii: heartjnl-2018-313705. doi: 10.1136/heartjnl-2018-313705
     PubMed     Text format     Abstract available
     
     
126. MAZNYCZKA AM, McCartney P, Berry C
     Reference invasive tests of microvascular injury in myocardial infarction.
     Heart. 2018;104:90-92.
     PubMed     Text format    
     
     
127. ARRI SS, Patterson T, Williams RP, Moschonas K, et al
     Myocardial revascularisation in high-risk subjects.
     Heart. 2018;104:166-179.
     PubMed     Text format    
     
     
128. BAENA-DIEZ JM, Garcia-Gil M, Comas-Cufi M, Ramos R, et al
     Association between chronic immune-mediated inflammatory diseases and cardiovascular risk.
     Heart. 2018;104:119-126.
     PubMed     Text format     Abstract available
     
     
129. DE WAARD GA, Fahrni G, de Wit D, Kitabata H, et al
     Hyperaemic microvascular resistance predicts clinical outcome and microvascular injury after myocardial infarction.
     Heart. 2018;104:127-134.
     PubMed     Text format     Abstract available
     
     

     
     Hypertension

130. LAMPREA-MONTEALEGRE JA, Zelnick LR, Hall YN, Bansal N, et al
     Prevalence of Hypertension and Cardiovascular Risk According to Blood Pressure Thresholds Used for Diagnosis.
     Hypertension. 2018;72:602-609.
     PubMed     Text format     Abstract available
     
     
131. 
     Correction to: Office Blood Pressure and Cardiovascular Disease: Pathophysiologic Implications for Diagnosis and Treatment.
     Hypertension. 2018;72:e31.
     PubMed     Text format    
     
     
132. MOE K, Alnaes-Katjavivi P, Storvold GL, Sugulle M, et al
     Classical Cardiovascular Risk Markers in Pregnancy and Associations to Uteroplacental Acute Atherosis.
     Hypertension. 2018;72:695-702.
     PubMed     Text format     Abstract available
     
     
133. KARIO K, Iwashita M, Okuda Y, Sugiyama M, et al
     Morning Home Blood Pressure and Cardiovascular Events in Japanese Hypertensive Patients.
     Hypertension. 2018;72:854-861.
     PubMed     Text format     Abstract available
     
     
134. JURASCHEK SP, Appel LJ, Miller ER 3rd, Mukamal KJ, et al
     Hypertension Treatment Effects on Orthostatic Hypotension and Its Relationship With Cardiovascular Disease.
     Hypertension. 2018;72:986-993.
     PubMed     Text format     Abstract available
     
     
135. 
     Comparison Between Valsartan and Amlodipine Regarding Cardiovascular Morbidity and Mortality in Hypertensive Patients With Glucose Intolerance: NAGOYA HEART Study.
     Hypertension. 2018;72:e37-e38.
     PubMed     Text format    
     
     
136. 
     Correction to: Surrogate Markers of Cardiovascular Risk and Chronic Obstructive Pulmonary Disease: A Large Case-Controlled Study.
     Hypertension. 2018;72:e30.
     PubMed     Text format    
     
     

     
     Int J Cardiol

137. SIMON TG, Trejo MEP, McClelland R, Bradley R, et al
     Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis.
     Int J Cardiol. 2018;259:198-204.
     PubMed     Text format     Abstract available
     
     
138. LORCHNER H, Widera C, Hou Y, Elsasser A, et al
     Reg3beta is associated with cardiac inflammation and provides prognostic information in patients with acute coronary syndrome.
     Int J Cardiol. 2018;258:7-13.
     PubMed     Text format     Abstract available
     
     
139. DE ROSA R, Palmerini T, De Servi S, Belmonte M, et al
     High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - Insight from the GEPRESS study.
     Int J Cardiol. 2018;259:20-25.
     PubMed     Text format     Abstract available
     
     
140. RODRIGUEZ-GRANILLO GA, Reynoso E, Capunay C, Carpio J, et al
     Pericardial and visceral, but not total body fat, are related to global coronary and extra-coronary atherosclerotic plaque burden.
     Int J Cardiol. 2018;260:204-210.
     PubMed     Text format     Abstract available
     
     
141. KOPPARA T, Tada T, Xhepa E, Kufner S, et al
     Randomised comparison of vascular response to biodegradable polymer sirolimus eluting and permanent polymer everolimus eluting stents: An optical coherence tomography study.
     Int J Cardiol. 2018;258:42-49.
     PubMed     Text format     Abstract available
     
     
142. PODOLEC J, Niewiara L, Skiba D, Siedlinski M, et al
     Higher levels of circulating naive CD8(+)CD45RA(+) cells are associated with lower extent of coronary atherosclerosis and vascular dysfunction.
     Int J Cardiol. 2018;259:26-30.
     PubMed     Text format    
     
     
143. CEDIEL G, Carrillo X, Garcia-Garcia C, Rueda F, et al
     beta-Blocker treatment and prognosis in acute coronary syndrome associated with cocaine consumption: The RUTI-Cocaine Study.
     Int J Cardiol. 2018;260:7-10.
     PubMed     Text format     Abstract available
     
     
144. DI MINNO MND, Di Minno A, Ambrosino P, Songia P, et al
     Cardiovascular morbidity and mortality in patients with aortic valve sclerosis: A systematic review and meta-analysis.
     Int J Cardiol. 2018;260:138-144.
     PubMed     Text format     Abstract available
     
     
145. PLANK F, Beyer C, Friedrich G, Stuhlinger M, et al
     Influence of vitamin K antagonists and direct oral anticoagulation on coronary artery disease: A CTA analysis.
     Int J Cardiol. 2018;260:11-15.
     PubMed     Text format     Abstract available
     
     
146. CASTELVECCHIO S, Baryshnikova E, Pina IL, Ambrogi F, et al
     Longitudinal profile of NT-proBNP levels in ischemic heart failure patients undergoing surgical ventricular reconstruction: The Biomarker Plus study.
     Int J Cardiol. 2018 Feb 26. pii: S0167-5273(17)36355.
     PubMed     Text format     Abstract available
     
     
147. ANDREINI D, Mushtaq S, Pontone G, Conte E, et al
     Diagnostic performance of coronary CT angiography carried out with a novel whole-heart coverage high-definition CT scanner in patients with high heart rate.
     Int J Cardiol. 2018;257:325-331.
     PubMed     Text format     Abstract available
     
     
148. DESCH S, Fuernau G, Poss J, Meyer-Saraei R, et al
     Impact of a novel contrast reduction system on contrast savings in coronary angiography - The DyeVert randomised controlled trial.
     Int J Cardiol. 2018;257:50-53.
     PubMed     Text format     Abstract available
     
     
149. SCHOFER N, Ludwig S, Rubsamen N, Schnabel R, et al
     Prognostic impact of Interleukin-1 receptor antagonist in patients with documented coronary artery disease.
     Int J Cardiol. 2018;257:24-29.
     PubMed     Text format     Abstract available
     
     
150. NICCOLI G, D'Amario D, Borovac JA, Santangelo E, et al
     Perilipin 2 levels are increased in patients with in-stent neoatherosclerosis: A clue to mechanisms of accelerated plaque formation after drug-eluting stent implantation.
     Int J Cardiol. 2018;258:55-58.
     PubMed     Text format     Abstract available
     
     
151. AZZALINI L, Demir OM, Gasparini GL, Grancini L, et al
     Outcomes of a novel thin-strut bioresorbable-polymer sirolimus-eluting stent in patients with chronic total occlusions: A multicenter registry.
     Int J Cardiol. 2018;258:36-41.
     PubMed     Text format     Abstract available
     
     
152. HEUSCH G, Skyschally A, Kleinbongard P
     Coronary microembolization and microvascular dysfunction.
     Int J Cardiol. 2018;258:17-23.
     PubMed     Text format     Abstract available
     
     
153. LU M, Wang S, Sirajuddin A, Arai AE, et al
     Dynamic stress computed tomography myocardial perfusion for detecting myocardial ischemia: A systematic review and meta-analysis.
     Int J Cardiol. 2018;258:325-331.
     PubMed     Text format     Abstract available
     
     
154. MAZZONE C, Cioffi G, Di Nora C, Barbati G, et al
     Prognostic role of cardiac calcifications in primary prevention: A powerful marker of adverse outcome highly dependent on underlying cardiac rhythm.
     Int J Cardiol. 2018;258:262-268.
     PubMed     Text format     Abstract available
     
     
155. DENOLLET J, van Felius RA, Lodder P, Mommersteeg PM, et al
     Predictive value of Type D personality for impaired endothelial function in patients with coronary artery disease.
     Int J Cardiol. 2018;259:205-210.
     PubMed     Text format     Abstract available
     
     
156. ARNADOTTIR A, Vestergaard KR, Pallisgaard J, Soletormos G, et al
     High-sensitivity cardiac troponin T is superior to troponin I in the prediction of mortality in patients without acute coronary syndrome.
     Int J Cardiol. 2018;259:186-191.
     PubMed     Text format     Abstract available
     
     
157. SAVONITTO S, Morici N, Franco N, Misuraca L, et al
     Age at menopause, extent of coronary artery disease and outcome among postmenopausal women with acute coronary syndromes.
     Int J Cardiol. 2018;259:8-13.
     PubMed     Text format     Abstract available
     
     
158. BAKY V, Moran D, Warwick T, George A, et al
     Obtaining a follow-up appointment before discharge protects against readmission for patients with acute coronary syndrome and heart failure: A quality improvement project.
     Int J Cardiol. 2018;257:12-15.
     PubMed     Text format     Abstract available
     
     
159. HUPIN D, Edouard P, Oriol M, Laukkanen J, et al
     Exercise electrocardiogram in middle-aged and older leisure time sportsmen: 100 exercise tests would be enough to identify one silent myocardial ischemia at risk for cardiac event.
     Int J Cardiol. 2018;257:16-23.
     PubMed     Text format     Abstract available
     
     
160. YU P, Zhao J, Jiang H, Liu M, et al
     Neural cell adhesion molecule-1 may be a new biomarker of coronary artery disease.
     Int J Cardiol. 2018;257:238-242.
     PubMed     Text format     Abstract available
     
     
161. CAPPELLETTI A, Astore D, Godino C, Bellini B, et al
     Relationship between Syntax Score and prognostic localization of coronary artery lesions with conventional risk factors, plasma profile markers, and carotid atherosclerosis (CAPP Study 2).
     Int J Cardiol. 2018;257:306-311.
     PubMed     Text format     Abstract available
     
     
162. MORRONE D, Felice F, Scatena C, De Martino A, et al
     Role of circulating endothelial progenitor cells in the reparative mechanisms of stable ischemic myocardium.
     Int J Cardiol. 2018;257:243-246.
     PubMed     Text format     Abstract available
     
     
163. KAWADA T
     Antidepressant medication and subsequent risk for acute coronary syndrome.
     Int J Cardiol. 2018;267:50-51.
     PubMed     Text format    
     
     
164. AVANZAS P, Sanchis J
     Selecting the best candidates for revascularization: A challenging issue in stable coronary artery disease.
     Int J Cardiol. 2018;267:52-53.
     PubMed     Text format    
     
     
165. KHAN TZ, de Silva R
     Is there a role for invasive assessment of the coronary microcirculation in patients with unobstructed epicardial coronary arteries in clinical practice?
     Int J Cardiol. 2018;267:46-47.
     PubMed     Text format    
     
     
166. GURUNATHAN S, Zacharias K, Akhtar M, Ahmed A, et al
     Cost-effectiveness of a management strategy based on exercise echocardiography versus exercise electrocardiography in patients presenting with suspected angina during long term follow up: A randomized study.
     Int J Cardiol. 2018;259:1-7.
     PubMed     Text format     Abstract available
     
     
167. CIRILLO P, Cimmino G, Conte S, Pellegrino G, et al
     Relationship between Pregnancy-associated Plasma Protein-A and tissue factor levels in the coronary circulation of patients with acute coronary syndrome.
     Int J Cardiol. 2018;258:14-16.
     PubMed     Text format    
     
     

     
     J Am Coll Cardiol

168. RAJAGOPALAN S, Al-Kindi SG, Brook RD
     Air Pollution and Cardiovascular Disease: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2018;72:2054-2070.
     PubMed     Text format     Abstract available
     
     
169. BRENER SJ, Serruys PW, Morice MC, Mehran R, et al
     Optimal Duration of Dual Antiplatelet Therapy After Left Main Coronary Stenting.
     J Am Coll Cardiol. 2018;72:2086-2087.
     PubMed     Text format    
     
     
170. KATES AM, Morris P, Poppas A, Kuvin JT, et al
     Impact of Live, Scientific Annual Meetings in Today's Cardiovascular World.
     J Am Coll Cardiol. 2018;72:2082-2085.
     PubMed     Text format     Abstract available
     
     
171. CHANDRASHEKHAR Y
     Diagnostic Testing in Coronary Artery Disease: Relieving the Stenosis, Attenuating Ischemia, or Preventing Hard Events?
     J Am Coll Cardiol. 2018;72:2135-2138.
     PubMed     Text format    
     
     
172. WILLIAMS JW, Giannarelli C, Rahman A, Randolph GJ, et al
     Macrophage Biology, Classification, and Phenotype in Cardiovascular Disease: JACC Macrophage in CVD Series (Part 1).
     J Am Coll Cardiol. 2018;72:2166-2180.
     PubMed     Text format     Abstract available
     
     
173. FAYAD ZA, Swirski FK, Calcagno C, Robbins CS, et al
     Monocyte and Macrophage Dynamics in the Cardiovascular System: JACC Macrophage in CVD Series (Part 3).
     J Am Coll Cardiol. 2018;72:2198-2212.
     PubMed     Text format     Abstract available
     
     
174. FUSTER V, Oetgen WJ
     JACC Serving the Global Cardiovascular Community.
     J Am Coll Cardiol. 2018 Oct 18. pii: S0735-1097(18)38675.
     PubMed     Text format    
     
     
175. ALOIA E
     DOACs Versus Warfarin in Preventing Myocardial Infarction: Are the Benefits Worth the Price?
     J Am Coll Cardiol. 2018;72:2092-2093.
     PubMed     Text format    
     
     
176. YE ZL, Guo WQ, Li L
     Non-VKA Oral Anticoagulant and Risk of Myocardial Infarction: Paradoxical Procoagulant Effect of Warfarin?
     J Am Coll Cardiol. 2018;72:2093.
     PubMed     Text format    
     
     
177. JI-YOUNG LEE C, Torp-Pedersen C
     Reply: DOACs Versus Warfarin in Preventing Myocardial Infarction: Are the Benefits Worth the Price?
     J Am Coll Cardiol. 2018;72:2093-2094.
     PubMed     Text format    
     
     
178. SCHUURMAN AS, Vroegindewey MM, Kardys I, Oemrawsingh RM, et al
     Prognostic Value of Intravascular Ultrasound in Patients With Coronary Artery Disease.
     J Am Coll Cardiol. 2018;72:2003-2011.
     PubMed     Text format     Abstract available
     
     
179. MAHMUD E, Ben-Yehuda O
     Percutaneous Coronary Intervention in Acute Coronary Syndrome: Completing the Job Saves Lives.
     J Am Coll Cardiol. 2018;72:2000-2002.
     PubMed     Text format    
     
     
180. RATHOD KS, Koganti S, Jain AK, Astroulakis Z, et al
     Complete Versus Culprit-Only Lesion Intervention in Patients With Acute Coronary Syndromes.
     J Am Coll Cardiol. 2018;72:1989-1999.
     PubMed     Text format     Abstract available
     
     

     
     J Cardiovasc Pharmacol

181. YUAN L, Tang C, Li D, Yang Z, et al
     microRNA-18a expression in female coronary heart disease and regulatory mechanism on endothelial cell by targeting estrogen receptorsss.
     J Cardiovasc Pharmacol. 2018 Oct 24. doi: 10.1097/FJC.0000000000000623.
     PubMed     Text format     Abstract available
     
     

     
     J Electrocardiol

182. RUIZ PIZARRO V, Palacios-Rubio J, Cobos-Gil MA
     Letter to the editor: Is "triangular QRS-ST-T waveform" a left main total occlusion marker?
     J Electrocardiol. 2018;51:378.
     PubMed     Text format    
     
     

     
     J Mol Cell Cardiol

183. YANG Z, Li C, Wang Y, Yang J, et al
     Melatonin attenuates chronic pain related myocardial ischemic susceptibility through inhibiting RIP3-MLKL/CaMKII dependent necroptosis.
     J Mol Cell Cardiol. 2018 Oct 23. pii: S0022-2828(18)30895.
     PubMed     Text format     Abstract available
     
     

     
     J Thorac Cardiovasc Surg

184. CHANCELLOR WZ, Kron IL
     A focused approach: Specialization in coronary revascularization.
     J Thorac Cardiovasc Surg. 2018 Sep 21. pii: S0022-5223(18)32351.
     PubMed     Text format    
     
     

     
     JAMA

185. SLOMSKI A
     No Cardiovascular Protection From Omega-3 Fatty Acids.
     JAMA. 2018;320:1631.
     PubMed     Text format    
     
     
186. ABBASI J
     To Prevent Cardiovascular Disease, Pay Attention to Pregnancy Complications.
     JAMA. 2018 Oct 17. pii: 2708197. doi: 10.1001/jama.2018.14645.
     PubMed     Text format    
     
     

     
     Lancet

187. CHU DK, Kim LH, Young PJ, Zamiri N, et al
     Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta-analysis.
     Lancet. 2018;391:1693-1705.
     PubMed     Text format     Abstract available
     
     

     
     Lancet Child Adolesc Health

188. BURNS JC, Hoshino S, Kobayashi T
     Kawasaki disease: an essential comparison of coronary artery aneurysm criteria.
     Lancet Child Adolesc Health. 2018 Oct 15. pii: S2352-4642(18)30334.
     PubMed     Text format    
     
     

     
     N Engl J Med

189. PEREZ-GOMEZ MV, Bartsch LA, Ortiz A
     Cardiovascular Safety of Febuxostat.
     N Engl J Med. 2018;379:1583.
     PubMed     Text format    
     
     
190. MONTENEGRO MF, Lundberg JO, Weitzberg E
     Cardiovascular Safety of Febuxostat.
     N Engl J Med. 2018;379:1583-4.
     PubMed     Text format    
     
     
191. BHATTACHARYYA S, Macklin EA, Schwarzschild MA
     Cardiovascular Safety of Febuxostat.
     N Engl J Med. 2018;379:1582.
     PubMed     Text format    
     
     

     
     PLoS One

192. LAKHANI HV, Khanal T, Gabi A, Yousef G, et al
     Developing a panel of biomarkers and miRNA in patients with myocardial infarction for early intervention strategies of heart failure in West Virginian population.
     PLoS One. 2018;13:e0205329.
     PubMed     Text format     Abstract available
     
     
193. HUANG CH, Li CL, Kor CT, Chang CC, et al
     Menopausal symptoms and risk of coronary heart disease in middle-aged women: A nationwide population-based cohort study.
     PLoS One. 2018;13:e0206036.
     PubMed     Text format     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Ischemic Heart Disease is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: